Rising global prevalence and incidence of obesity lead to increased cardiovascular-renal complications and cancers. Epidemiological studies reported a worldwide trend towards suboptimal sleep duration and poor sleep quality in parallel with this obesity epidemic. From rodents and human models, it is highly plausible that abnormalities in sleep, both quantity and quality, impact negatively on energy metabolism. While excess dietary intake and physical inactivity are the known drivers of the obesity epidemic, promotion of healthy sleep habits has emerged as a new target to combat obesity. In this light, present review focuses on the existing literature examining the relationship between sleep physiology and energy homeostasis. Notably, sleep dysregulation perturbs the metabolic milieu via alterations in hormones such as leptin and ghrelin, eating behavior, neuroendocrine and autonomic nervous systems. In addition, shift work and trans-meridian air travel may exert a negative influence on the hypothalamic-pituitary-adrenal axis and trigger circadian misalignment, leading to impaired glucose tolerance and increased fat accumulation. Amassing evidence has also suggested that uncoupling of the circadian clock can increase the risk of adverse metabolic health. Given the importance of sleep in maintaining energy homeostasis and that it is potentially modifiable, promoting good sleep hygiene may create new avenues for obesity prevention and treatment.
INTRODUCTION
The global prevalence of obesity has doubled since 1980, affecting 107.7 million children and 603.7 million adults in 2015, with more than two-thirds of the United States population being either overweight or obese. 1 This rapid surge in obesity is driven mainly by lifestyle factors such as physical inactivity, unhealthy dietary choices and patterns. 2 Emerging evidence suggests that sleep disturbances (e.g., suboptimal sleep duration, poor sleep quality, circadian misalignment and insomnia), may contribute to obesity and type 2 diabetes mellitus (T2DM). 2 Physiologically, sleep duration declines during transition from infancy, puberty to late adulthood. 3 Optimal sleep duration has been a matter of controversy but recent consensus of the American Academy of Sleep Medicine defines short sleep duration as < 8-10 hours and < 7 hours per day in adolescents and adults aged 18-60 years respectively, considering the potential risks in association with the development of cardiometabolic disease and death. [4] [5] [6] Due to increasing demand from school, work and leisure activities , as well as high consumption of carbohydrate-rich night-time snacks. 20 These were accompanied by a lack of compensatory increase or even with a reduction in 24-hour energy expenditure, leading to positive energy balance. 19, 20 In keeping with these findings, an inverse relationship between sleep duration and total energy and macronutrient intake was evident in epidemiological cohorts. 15, 17, 21, 22 In a meta-analysis of 14,906 Europeans from the Cohorts for the Heart and Aging Research in Genomic Epidemiology Consortium, younger people (aged 20-64 years)
with short sleep duration were independently associated with higher relative saturated fatty acids intake, whereas older women (aged 65-80 years) with similar exposure demonstrated higher relative carbohydrate, lower relative total fat and polyunsaturated fatty acids consumption. 22 In the 2005-2010 U.S. National Health and Nutrition Examination Survey involving 15,199 community-dwelling adults, short sleepers reported frequent snacking and increased total glucose intake. 17 Similarly, amongst 2,828 Chinese adults, those with less than 7-hour sleep had excess fat intake than the group with 7-to 9-hour sleep. 21 Accumulating evidence suggests that sleep disruption may interfere with the feeding and satiety signals at the hypothalamic feeding circuits. 23 A shift towards increased hunger in short sleepers was driven by decreased leptin level with or without a concomitant change in the diurnal rhythm amplitude of leptin, increased ghrelin level or both. 24, 25 In healthy young adults with stable caloric intake and activity levels, 6 days of sleep restriction (4 hours in bed per night) was independently associated with a 26% reduction in leptin than sleep extension (12 hours in bed per night), on top of a flattened diurnal profile of leptin secretion. 25 In the prospective Wisconsin Sleep Cohort Study involving 1,024 healthy adults, compared with those with 8-hour of sleep, short sleepers (5-hour of sleep per day) had a 16% decrease in leptin and 15% increase in ghrelin level. 24 Interestingly, diminished activity of the appetitive desire and food stimulus evaluation regions within the frontal, insular and cingulate cortices, along with enhanced activity of amygdala are other plausible pathways linking sleep curtailment to obesity. [26] [27] [28] The disrupted neural circuits led to hedonic hunger and preferences for highly palatable and rewarding energy-dense food [26] [27] [28] , albeit with inter-individual variation in the magnitude of change in eating behavior proportional to the severity of sleep curtailment.
promotes obesogenic eating behavior e.g., meal-skipping, frequent snacking and increase intake of low-quality diet. 17, 29, 30 Late-time eating, which was defined as caloric intake after 8:00 PM, also significantly predicted an increase in BMI, suggesting that eating late at night may lead to obesity. 29 Moreover, decreased nocturnal ghrelin levels were found in men with insomnia compared with their ageand body weight-matched healthy control (n = 25), while no difference of leptin levels was found between groups.
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Sleep and growth hormone-insulin like growth factor-1 axis
The growth hormone (GH)-insulin like growth factor-1 (IGF-1)
axis also plays a role in the regulation of adiposity and glucose homeostasis. Under a normal sleep/wake cycle, there is a spontaneous nocturnal GH pulse during the restorative slow wave sleep (SWS) that occurs within the first 3 hours of sleep, with both demonstrating a dose-dependent relationship. 32 Increasing evidence suggests that there are biological interactions of GH/IGF-1 axis with sleep dysregulation. Sleep curtailment and late chronotype are associated with suppressed GH and IGF-1 pulsatility, followed by a compensatory increase in IGF-binding protein 3 (IGFBP-3) level via the negative feedback loop. 33 In a 4-year prospective cohort study of normoglycemic adults, low circulating IGF-1 level had a 50% excess risk of developing either impaired glucose tolerance or T2DM, consequent to decreased peripheral insulin sensitivity and hyperinsulinemia. 34 In the Danish-Monitoring Trends in Cardiovascular Diseases study, after a mean follow-up of 15 years, either a low IGF-1 or high IGFBP-3 level was independently associated with a relative risk (RR) of 1.94-2.22 of incident coronary heart disease, after adjustment for other cardiovascular risk factors. 35 Several mechanisms were postulated to explain the pleiotropic effects of GH/IGF-1 axis on the retardation of atherosclerosis e.g., reduced systemic and vascular oxidative stress (low interleukin-6 and tumor necrosis factor-alpha levels), decreased aortic stiffness and control of de novo hepatic lipid metabolism. 35, 36 In contrast to the aforementioned findings, another experimental sleep restriction (4 hours in bed per night for six consecutive nights) study involving 11 healthy young men revealed a biphasic pattern of nocturnal GH release, with the first pulse occurred at 3-hour prior to the sleep onset and the second peak corresponded to the usual circadian rhythm as seen during the sleep extension period (12 hours in bed per night for a week). 32 This prolonged exposure to elevated GH level may interact with the hunger-promoting ghrelin centrally or stimulate peripheral glucose and lipid catabolism, resulting in insulin resistance and positive energy balance. 37 These findings were supported by some but not all observational studies, which reported a U-shaped relationship between IGF-1 to IGFBP-3 ratio, anthropometric traits (e.g., BMI and waist circumference) or risk of metabolic syndrome. 38, 39 To this end, a better understanding of the cellular-microenvironment interactions and their downstream signaling cascades integrating sleep, GH/IGF-1 axis and metabolic functions is warranted. 47 Poor sleep quality has been reported to be an independent stressor for excess cortisol and catecholamines secretion, particularly with greater magnitude in adolescents at late puberty. 42, 44 Increased HPA axis activation has also been reported in subjects with insomnia. 48, 49 Furthermore, it has been suggested that a gender difference on this stress reaction related to sleep disturbances which may be modulated by the type of sleep disorders involved, calling for more studies to investigate the impact of sex hormones on sleep and energy balance. 44, 50 Sympathetic over-activity may also contribute to the neurohormonal dysregulation linking sleep curtailment to energy imbalance.
Sleep and hypothalamic-pituitary-adrenal axis
In addition to a 1. Although the pathophysiology of insomnia is still not fully understood, it has long been considered to be a disorder of hyperarousal during both daytime and nighttime, which is associated with increased activation of whole-body and brain metabolism, hyperactivity of HPA axis and hormonal dysregulation. 49 A study involving 1,042 monozygotic and 828 dizygotic twin pairs demonstrated a 10% phenotypic correlation between insomnia and obesity, suggesting a shared genetic mechanism that underlies these conditions. 105 However, the findings about this association were inconsistent in other clinical studies, which mostly reported either no association or an inverse relationship between insomnia and BMI. In a cross-sectional study conducted in 211 Finnish men aged years, among the overweight or obese participants (n = 163), those with insomnia (n = 40) had higher fat mass in the trunk and android regions than the group without sleep disorder (n = 76, P < 0.05), but no between-group differences in BMI or total fat mass. 95 There was also no difference in BMI when comparing 141 
SLEEP AND GENES REGULATING THE CIRCADIAN CLOCK
Clock genes may play a key role in linking sleep and the effect of circadian disruptions on metabolic functions. 23 A central clock which is located within the suprachiasmatic nuclei of the hypothalamus orchestrates the environmental light/dark cycles with human physiology and behavior. Genetic or environmental perturbations of this synchronized molecular mechanism can lead to metabolic disturbances. In the core clock mechanism, the brain and muscle
Arnt like protein-1 (BMAL1)/circadian locomotor output cycles kaput (CLOCK) heterodimer binds to the E-box elements in the promoter regions of Per and Cry genes, thus activating their transcription proteins with feedback inhibition on the BMAL1/ CLOCK. 112 Six hours of sleep curtailment was sufficient to reduce BMAL1 binding to the E-box elements of Per gene. 23 Other important regulators that integrate the effects of circadian clock on metabolic pathways include the clock-controlled genes and certain transcription factors e.g., REV-ERBα, retinoid-related orphan receptor α, and peroxisome proliferator-activated receptor α. 2, 113 These genes can also be categorized by type of regulations e.g., circadian cycle only (BMAL1), sleep-wake cycle only (Homer1a) or both (Per).
Hence, the effects of sleep on gene expression, subsequent epigenetic modifications and metabolic perturbations require further translational research to improve our understanding about the genes involved and the details of the regulation. 23 Coordination of the sleep/wake cycle as well as the metabolic and fasting/feeding cycle are all essential to maintain a normal circadian oscillatory system for healthy bodily functions. Glucose homeostasis is regulated by both the central clock that synchronizes sleep and feeding, and peripheral tissue clocks that coordinate one's behavior with glucose synthesis and utilization. 114 When BMAL1/ CLOCK heterodimer colocalizes with the pancreatic transcription factor pancreatic and duodenal homeobox 1 on the regulatory sites of beta-cell cycling genes, pancreatic beta-cell maturation is enhanced with possible pulsatile insulin secretion according to the circadian rhythmicity. 114 Similarly, BMAL1-ablation in mice reduces insulin exocytosis from pancreatic beta-cell, resulting in hyperglycemia. 23 Based on the genome-wide association studies, individuals with T2DM and melatonin receptor 1B (MTNR1B) risk allele may have high melatonin level that interacts with dietary intake, with subsequent impairment in glucose metabolism and increased risk of T2DM. 23 Conditions that are often associated with circadian misalignment are shift work and trans-meridian air travel (jet lag). Shift work can desynchronize the central and peripheral circadian clocks, which further perturbs the glucose metabolism by decreasing insulin sensitivity, independent of sleep curtailment. 23, 115 In healthy adults, 3-week sleep curtailment with concomitant circadian misalignment is demonstrated to reduce the resting metabolic rate and impair pancreatic beta-cell secretion. 116 In mice model, chronic jet lag disrupts the circadian cycle by uncoupling the central and peripheral clocks in the adipose tissue, and triggers leptin resistance leading to development of obesity, an effect independent of other risk factors. 117 In the large prospective Nurses' Health Study 2, early chronotype combined with increasing years of rotating night shift work aggravated diabetes risk, even after adjustment for patients' attributes, family history of diabetes, diet, physical activity and self-reported sleep duration. 118 Interestingly, late chronotype alone predicted a 51% (hazard ratio, 1.51; 95% CI, 1.13-2.03) excess risk of developing T2DM, which was attenuated by longer night shift exposure, presumably due to less interference to the "usual" circadian rhythm. 118 These findings support the notion that chronotypeadapted work schedules can possibly reduce the circadian misalignment and prevent future cardiometabolic risk.
The circadian clock has been demonstrated to regulate the diurnal fluctuations of certain human metabolites such as the fatty acids and amino acids, independent of the fasting/feeding cycle. 119 In the first human metabolomics study conducted during a 48-hour sleep/wake cycle, 27 of the 171 measured metabolites (e.g., fatty acids, tryptophan, taurine, and serotonin) were significantly elevated with sleep curtailment. 120 This creates novel opportunities for potential therapeutic intervention targeting the key clock-regulated metabolic pathways and application of these noninvasive biomarkers for disease prediction and monitoring.
CONCLUSION
Good sleep hygiene is crucial to maintain optimal functions of the neuroendocrine and appetite regulation systems. 
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